These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19800113)

  • 1. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
    Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
    Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting.
    Morille M; Passirani C; Letrou-Bonneval E; Benoit JP; Pitard B
    Int J Pharm; 2009 Sep; 379(2):293-300. PubMed ID: 19505548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor transfection after systemic injection of DNA lipid nanocapsules.
    Morille M; Passirani C; Dufort S; Bastiat G; Pitard B; Coll JL; Benoit JP
    Biomaterials; 2011 Mar; 32(9):2327-33. PubMed ID: 21185595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model.
    David S; Montier T; Carmoy N; Resnier P; Clavreul A; Mével M; Pitard B; Benoit JP; Passirani C
    J Gene Med; 2012 Dec; 14(12):769-75. PubMed ID: 23143656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model.
    David S; Carmoy N; Resnier P; Denis C; Misery L; Pitard B; Benoit JP; Passirani C; Montier T
    Int J Pharm; 2012 Feb; 423(1):108-15. PubMed ID: 21726617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanocapsules: a new platform for nanomedicine.
    Huynh NT; Passirani C; Saulnier P; Benoit JP
    Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
    Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
    ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
    Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
    Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy.
    Jestin E; Mougin-Degraef M; Faivre-Chauvet A; Remaud-Le Saëc P; Hindre F; Benoit JP; Chatal JF; Barbet J; Gestin JF
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):51-60. PubMed ID: 17372573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
    Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
    Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery.
    Heyes J; Hall K; Tailor V; Lenz R; MacLachlan I
    J Control Release; 2006 May; 112(2):280-90. PubMed ID: 16603272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
    Li W; Huang Z; MacKay JA; Grube S; Szoka FC
    J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid.
    Hatakeyama H; Akita H; Kogure K; Oishi M; Nagasaki Y; Kihira Y; Ueno M; Kobayashi H; Kikuchi H; Harashima H
    Gene Ther; 2007 Jan; 14(1):68-77. PubMed ID: 16915290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.
    Resnier P; David S; Lautram N; Delcroix GJ; Clavreul A; Benoit JP; Passirani C
    Int J Pharm; 2013 Oct; 454(2):748-55. PubMed ID: 23583841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
    Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T
    Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.
    Resnier P; LeQuinio P; Lautram N; André E; Gaillard C; Bastiat G; Benoit JP; Passirani C
    Biotechnol J; 2014 Nov; 9(11):1389-401. PubMed ID: 25262914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adaptation of lipid nanocapsule formulations for blood administration in animals.
    Hureaux J; Lagarce F; Gagnadoux F; Clavreul A; Benoit JP; Urban T
    Int J Pharm; 2009 Sep; 379(2):266-9. PubMed ID: 19467305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection.
    Monck MA; Mori A; Lee D; Tam P; Wheeler JJ; Cullis PR; Scherrer P
    J Drug Target; 2000; 7(6):439-52. PubMed ID: 10758914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA.
    Fujita T; Furuhata M; Hattori Y; Kawakami H; Toma K; Maitani Y
    J Control Release; 2008 Jul; 129(2):124-7. PubMed ID: 18513820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.